CIK 0002079109 · <br>Emerging growth company
Veraxa Biotech AG - Post de-SPAC
Sign in to watch- Ticker
- VRXA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- other
- Phone
- 41443858450
- Business address
- TALACKER 35, ZURICH, Switzerland, 8001
- Former names
- Veraxa Biotech Holding AG
Securities
- VRXA Ordinary Shares Nasdaq
- VRXAW Warrants Nasdaq
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- F-4/A Deal Registration of Securities, Foreign Private Issuers, Business Combinations
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- F-4/A Deal Registration of Securities, Foreign Private Issuers, Business Combinations
- CORRESP Other Correspondence Between Filers and SEC Staff
- F-4/A Deal Registration of Securities, Foreign Private Issuers, Business Combinations
- UPLOAD Other SEC-generated Letter
- 425 Deal Prospectus/Communication re Business Combination
- F-4/A Deal Registration of Securities, Foreign Private Issuers, Business Combinations
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- F-4/A Deal Registration of Securities, Foreign Private Issuers, Business Combinations
- F-4 Deal Registration of Securities, Foreign Private Issuers, Business Combinations
Page 3 of 3 · 56 filings